Skip to main content
. 2018 May 24;7:e34711. doi: 10.7554/eLife.34711

Table 7. Enantiomeric preference of EU1794-27.

EC50 (µM) [conf. int.]*
Maximal Modulation Extent (% of control)
Compound EU1794-27 (-)-EU1794-27 (+)-EU1794-27
GluN2A 7.4 [5.3, 10]
52 ± 7%
5.6 [2.7, 12]
67 ± 5%
-
GluN2B 1.4 [1.2, 1.7]
130 ± 3%
2.8 [2.0, 3.8]
170 ± 10%
-
GluN2C 2.8 [2.5, 3.2]
230 ± 10%
5.1 [4.1, 6.4]
260 ± 24%
7.1 [3.6, 14]
160 ± 6.2%
GluN2D 2.4 [1.8, 3.3]
250 ± 8%
8.2 [6.7, 9.9]
340 ± 21%
7.4 [3.7, 15]
130 ± 4.7%

*EC50 values were obtained by least-squares fitting of data from individual experiments by the Hill equation. EC50 values are given as the mean with the 95% confidence interval determined from log(EC50); the maximal degree of modulation is given as mean ±SEM. Data are from 4 to 7 oocytes from at least two independent experiments. Data were not fitted (shown as -) if the response recorded at 30 µM of test compound did not differ by more than 15% from control.

Data from Table 1 is included here for clarity.

indicates significant unpaired t-test between the percent modulation between 30 µM (-)-EU1794-27 and (+)-EU1794-27.